• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同未折叠蛋白反应活性状态下肝细胞癌微环境的改变

Alterations of the microenvironment of hepatocellular carcinoma in different unfolded protein response activity states.

作者信息

Wang Yao, Zhu Xiao Fei, Gu Wan Jian, Zhang Gui Hong

机构信息

Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, No. 155, Han'Zhong Road, Qinhuai, Nanjing, 210029, Jiangsu, China.

出版信息

Discov Oncol. 2025 Mar 25;16(1):393. doi: 10.1007/s12672-025-02164-4.

DOI:10.1007/s12672-025-02164-4
PMID:40133716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11937449/
Abstract

BACKGROUND

The unfolded protein response (UPR) is an adaptive and cytoprotective sensing-signaling network. Numerous studies have indicated the crucial role of UPR in the anti-tumor drug resistance and the modification of tumor microenvironment (TME). The aim of this study is to analyze the alterations of microenvironment and key regulatory genes in hepatocellular carcinoma (HCC) with high UPR activity.

METHODS

We profiled differentially expressed genes (DEGs) by UPR activity, and the biological functions of DEGs and the alterations of signaling pathways were explored. The Immune/Stromal scores and relative abundance of infiltrating cells of HCC tissues with RNA sequencing data downloaded from The Cancer Genome Atlas (TCGA) were calculated by the xCell and ESTIMATE algorithm. The correlations between the prognostic UPR-related genes with the microenvironment scores and infiltrating cells were analyzed using R package "corrplot".

RESULTS

Our results demonstrated that UPR-related genes mainly involved in immune-related signaling pathways. Microenvironment analysis revealed that HCC tissues with higher UPR activity had lower Stromal scores and the relative abundance of various infiltrating cells including hematopoietic stem cells (HSC), lymphatic endothelial cells (LECs), microvascular endothelial cells, endothelial cells (ECs) and adipocytes decreased most significantly. Kaplan-Meier survival analysis indicated that the decline of Stromal scores and corresponding infiltrating stromal cells would result in worse prognosis. The expression levels of CLEC3B, RAMP3, GPR182 and DNASE1L3 were significantly positively correlated with Stromal scores and various infiltrating stromal cells, and down-regulation of these genes were also associated with worse prognosis of HCC.

CONCLUSIONS

HCC with high UPR activity had lower Stromal scores and worse prognosis. Down-regulated genes CLEC3B, RAMP3, GPR182 and DNASE1L3 may play an important regulatory role in the modification of microenvironment of HCC with high UPR activity.

摘要

背景

未折叠蛋白反应(UPR)是一种适应性和细胞保护的传感信号网络。大量研究表明UPR在抗肿瘤耐药性及肿瘤微环境(TME)重塑中起关键作用。本研究旨在分析具有高UPR活性的肝细胞癌(HCC)中微环境及关键调控基因的变化。

方法

我们根据UPR活性对差异表达基因(DEG)进行了分析,并探究了DEG的生物学功能及信号通路的变化。通过xCell和ESTIMATE算法,利用从癌症基因组图谱(TCGA)下载的RNA测序数据计算HCC组织的免疫/基质评分及浸润细胞的相对丰度。使用R包“corrplot”分析与预后相关的UPR基因与微环境评分及浸润细胞之间的相关性。

结果

我们的结果表明,与UPR相关的基因主要参与免疫相关信号通路。微环境分析显示,具有较高UPR活性的HCC组织的基质评分较低,包括造血干细胞(HSC)、淋巴管内皮细胞(LEC)、微血管内皮细胞、内皮细胞(EC)和脂肪细胞在内的各种浸润细胞的相对丰度下降最为显著。Kaplan-Meier生存分析表明,基质评分及相应浸润性基质细胞的下降会导致预后更差。CLEC3B、RAMP3、GPR182和DNASE1L3的表达水平与基质评分及各种浸润性基质细胞显著正相关,这些基因的下调也与HCC的预后较差有关。

结论

具有高UPR活性的HCC基质评分较低,预后较差。下调基因CLEC3B、RAMP3、GPR182和DNASE1L3可能在具有高UPR活性的HCC微环境重塑中起重要调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/5d38405c95ac/12672_2025_2164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/e80ff6034e1b/12672_2025_2164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/2d92c3739a41/12672_2025_2164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/03f529deb44f/12672_2025_2164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/45838fa18854/12672_2025_2164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/5d38405c95ac/12672_2025_2164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/e80ff6034e1b/12672_2025_2164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/2d92c3739a41/12672_2025_2164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/03f529deb44f/12672_2025_2164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/45838fa18854/12672_2025_2164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e89e/11937449/5d38405c95ac/12672_2025_2164_Fig5_HTML.jpg

相似文献

1
Alterations of the microenvironment of hepatocellular carcinoma in different unfolded protein response activity states.不同未折叠蛋白反应活性状态下肝细胞癌微环境的改变
Discov Oncol. 2025 Mar 25;16(1):393. doi: 10.1007/s12672-025-02164-4.
2
Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中预后相关肿瘤微环境基因的生物信息学分析。
Med Sci Monit. 2020 Mar 31;26:e922159. doi: 10.12659/MSM.922159.
3
Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma.基于未折叠蛋白反应(UPR)相关分子亚型的肝细胞癌免疫原性景观和风险评分预测。
Front Immunol. 2023 Jun 30;14:1202324. doi: 10.3389/fimmu.2023.1202324. eCollection 2023.
4
Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.鉴定与肿瘤微环境相关的新型长链非编码RNA以确定肝细胞癌患者的预后及对免疫治疗的反应
Front Mol Biosci. 2021 Dec 24;8:781307. doi: 10.3389/fmolb.2021.781307. eCollection 2021.
5
Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.肝细胞癌患者一种新型肿瘤微环境相关预后特征的鉴定与验证
Front Mol Biosci. 2022 Jun 30;9:917839. doi: 10.3389/fmolb.2022.917839. eCollection 2022.
6
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中的预后基因鉴定。
Front Immunol. 2021 Apr 7;12:653836. doi: 10.3389/fimmu.2021.653836. eCollection 2021.
7
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).肝细胞癌(HCC)肿瘤微环境中预后免疫相关基因的综合分析。
Medicine (Baltimore). 2021 Oct 1;100(39):e27332. doi: 10.1097/MD.0000000000027332.
8
Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.肺腺癌肿瘤微环境中预后基因的分析
PeerJ. 2020 Jul 23;8:e9530. doi: 10.7717/peerj.9530. eCollection 2020.
9
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.TCGA 数据库中肿瘤微环境相关基因对直肠癌的预后价值。
J Cell Mol Med. 2021 Jun;25(12):5811-5822. doi: 10.1111/jcmm.16547. Epub 2021 May 5.
10
Construction of a tumor immune microenvironment-related risk scoring model for prognosis of hepatocellular carcinoma.构建用于肝细胞癌预后的肿瘤免疫微环境相关风险评分模型。
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251333975. doi: 10.1177/03946320251333975. Epub 2025 Apr 23.

本文引用的文献

1
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells.GRP78-CAR T 细胞对实体瘤和脑肿瘤的效应功能受 T 细胞上 GRP78 表达的控制。
Cell Rep Med. 2023 Nov 21;4(11):101297. doi: 10.1016/j.xcrm.2023.101297.
2
Tumor-associated endothelial cell prognostic risk model and tumor immune environment modulation in liver cancer based on single-cell and bulk RNA sequencing: Experimental verification.基于单细胞和批量RNA测序的肝癌肿瘤相关内皮细胞预后风险模型及肿瘤免疫环境调控:实验验证
Int Immunopharmacol. 2023 Nov;124(Pt A):110870. doi: 10.1016/j.intimp.2023.110870. Epub 2023 Sep 9.
3
DNASE1L3 enhances antitumor immunity and suppresses tumor progression in colon cancer.
DNASE1L3 增强结肠癌的抗肿瘤免疫并抑制肿瘤进展。
JCI Insight. 2023 Sep 8;8(17):e168161. doi: 10.1172/jci.insight.168161.
4
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.肿瘤微环境介导的肝细胞癌免疫逃逸。
Front Immunol. 2023 Feb 10;14:1133308. doi: 10.3389/fimmu.2023.1133308. eCollection 2023.
5
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.脱氧核糖核酸酶1样蛋白3通过抑制细胞周期蛋白依赖性激酶2(CDK2)介导的细胞周期进程来抑制肝细胞癌。
Cell Oncol (Dordr). 2022 Dec;45(6):1187-1202. doi: 10.1007/s13402-022-00709-1. Epub 2022 Nov 3.
6
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity.解码癌细胞中的内质网应激信号与抗肿瘤免疫。
Trends Cancer. 2022 Nov;8(11):930-943. doi: 10.1016/j.trecan.2022.06.006. Epub 2022 Jul 8.
7
Receptor Activity Modifying Protein RAMP Sub-Isoforms and Their Functional Differentiation, Which Regulates Functional Diversity of Adrenomedullin.受体活性修饰蛋白RAMP亚型及其功能分化,其调节肾上腺髓质素的功能多样性。
Biology (Basel). 2022 May 21;11(5):788. doi: 10.3390/biology11050788.
8
Down-regulation of CLEC3B facilitates epithelial-mesenchymal transition, migration and invasion of lung adenocarcinoma cells.下调 CLEC3B 促进肺腺癌细胞的上皮-间充质转化、迁移和侵袭。
Tissue Cell. 2022 Jun;76:101802. doi: 10.1016/j.tice.2022.101802. Epub 2022 Apr 22.
9
A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPR axis.一种新型的 HIF-2α 靶向抑制剂通过 SOD2-mtROS-PDI/GPR78-UPR 轴抑制低氧诱导的乳腺癌干细胞特性。
Cell Death Differ. 2022 Sep;29(9):1769-1789. doi: 10.1038/s41418-022-00963-8. Epub 2022 Mar 17.
10
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.GPR182 通过清除趋化因子限制小鼠黑色素瘤模型中的抗肿瘤免疫。
Nat Commun. 2022 Jan 10;13(1):97. doi: 10.1038/s41467-021-27658-x.